Copyright
©The Author(s) 2019.
World J Cardiol. Feb 26, 2019; 11(2): 57-70
Published online Feb 26, 2019. doi: 10.4330/wjc.v11.i2.57
Published online Feb 26, 2019. doi: 10.4330/wjc.v11.i2.57
Complication | Incidence | Treatment |
Pericardial effusion/tamponade that require intervention[47,48,50,51,53,56-58,63,76] | 1.2% to 5% | Pericardiocentesis |
Device embolization[47,48,50,51,56-58,63,76] | 0% to 3.7% | Transcatheter removal or surgery |
Device related thrombus[47,56-58,63] | Up to 14% | Anticoagulation |
Persistent ASD[77] | 11% at 6 mo and 7% at 12 mo | Usually small no need for treatment |
Cardiac perforation[51] | 0% to 0.4% | surgery |
Procedure related stroke[47,48,51,53,56-58,76] | 0% to 1.1% | Stroke management |
- Citation: Moussa Pacha H, Al-khadra Y, Soud M, Darmoch F, Moussa Pacha A, Alraies MC. Percutaneous devices for left atrial appendage occlusion: A contemporary review. World J Cardiol 2019; 11(2): 57-70
- URL: https://www.wjgnet.com/1949-8462/full/v11/i2/57.htm
- DOI: https://dx.doi.org/10.4330/wjc.v11.i2.57